Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1700 of 3284 entries
View as:

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics After High Single Ascending Oral Doses of AZD1656 in T2DM Patients

Phase: N/A Priority: Normal
NCT ID: NCT01221545 Org: User:
Start: 10/31/10 End: 01/31/11 Due: 01/31/12

Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02075255 Org: User:
Start: 04/28/14 End: 08/08/16 Due: 08/08/17

Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)

Phase: N/A Priority: Normal
NCT ID: NCT00306891 Org: User:
Start: 06/30/06 End: 09/30/08 Due: 09/30/09

Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01001494 Org: User:
Start: 10/31/09 End: 11/30/10 Due: 11/30/11

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT00206154 Org: User:
Start: 04/30/05 End: 12/31/06 Due: 12/31/07

Reflux Esophagitis Phase III Study (Initial Treatment)

Phase: N/A Priority: Normal
NCT ID: NCT00633932 Org: User:
Start: 12/31/07 End: 12/31/08 Due: 12/31/09

Study to Assess the Pharmacokinetic Bioequivalence of Budesonide and Albuterol With an Alternate Propellant Compared to Current Propellant.

Phase: N/A Priority: Normal
NCT ID: NCT06139991 Org: User:
Start: 11/16/23 End: 05/04/24 Due: 05/04/25

Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT01689389 Org: User:
Start: 12/31/12 End: 12/31/14 Due: 12/31/15

Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01003184 Org: User:
Start: 10/31/09 End: 12/31/11 Due: 12/31/12

Asociación Española de Gastroenterologia (Spanish Gastroenterology Association) Gastroesophageal Reflux Disease Guideline - Prospective Study

Phase: N/A Priority: Normal
NCT ID: NCT00697008 Org: User:
Start: 12/31/07 End: - Due: -

Study in Healthy Males to Assess Bioavailability of 4 Different Fostamatinib Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01208155 Org: User:
Start: 09/30/10 End: 11/30/10 Due: 11/30/11

Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00936221 Org: User:
Start: 07/31/09 End: 11/30/14 Due: 11/30/15

Phase I Multiple-Ascending Dose (Japan)

Phase: N/A Priority: Normal
NCT ID: NCT00538174 Org: User:
Start: 11/30/07 End: 05/31/08 Due: 05/31/09

Determine the Effect of Multiple Doses of AZD7325, CYP Study

Phase: N/A Priority: Normal
NCT ID: NCT00790114 Org: User:
Start: 07/31/08 End: 09/30/08 Due: 09/30/09

Study to Assess Effect of Cyclosporine on the Blood Levels of Ticagrelor

Phase: N/A Priority: Normal
NCT ID: NCT01504906 Org: User:
Start: 01/31/12 End: 06/30/12 Due: 06/30/13

Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04964908 Org: User:
Start: 12/03/21 End: 08/31/23 Due: 08/31/24

A Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02749435 Org: User:
Start: 05/03/16 End: 10/13/16 Due: 10/13/17

Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT05062759 Org: User:
Start: 08/23/21 End: 07/18/22 Due: 07/18/23

Acid-Associated Heartburn Symptoms and Dose of Esomeprazole

Phase: N/A Priority: Normal
NCT ID: NCT00206024 Org: User:
Start: 11/30/04 End: 07/31/05 Due: 07/31/06

Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00099619 Org: User:
Start: 09/30/04 End: 08/31/05 Due: 08/31/06

Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208)

Phase: N/A Priority: Normal
NCT ID: NCT00163371 Org: User:
Start: 09/30/05 End: 12/31/05 Due: 12/31/06

Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00241462 Org: User:
Start: 06/30/05 End: 12/31/09 Due: 12/31/10

Iressa Follow-up Trial

Phase: N/A Priority: Normal
NCT ID: NCT00357734 Org: User:
Start: 01/31/05 End: 05/31/15 Due: 05/31/16

A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)

Phase: N/A Priority: Normal
NCT ID: NCT00734097 Org: User:
Start: 11/30/07 End: 10/31/08 Due: 10/31/09

Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)

Phase: N/A Priority: Normal
NCT ID: NCT06087835 Org: User:
Start: 11/07/23 End: 01/22/27 Due: 01/22/28